Clear Gene Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
Clear Gene General Information
Description
Developer of ribonucleic acid diagnostics tests designed to provide coronavirus, cancer, and residual disease detection. The company utilizes the concept of genomics and machine learning to detect remaining solid tumors, along with isothermal tests to replace PCR, enabling healthcare professionals to provide treatments to patients.
Contact Information
Website
www.cleargene.comCorporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Corporate Office
- 930 Brittan Avenue
- San Carlos, CA 94070
- United States
Clear Gene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Grant | 07-Jun-2019 | $293K | $150K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2018 | $150K | $150K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Clear Gene Patents
Clear Gene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018428853-A1 | Methods and compositions for the analysis of cancer biomarkers | Active | 22-Jun-2018 | ||
| AU-2018428853-B2 | Methods and compositions for the analysis of cancer biomarkers | Active | 22-Jun-2018 | ||
| AU-2025279660-A1 | Methods and compositions for the analysis of cancer biomarkers | Pending | 22-Jun-2018 | ||
| CA-3103572-A1 | Methods and compositions for the analysis of cancer biomarkers | Pending | 22-Jun-2018 | ||
| EP-3810807-A1 | Methods and compositions for the analysis of cancer biomarkers | Pending | 22-Jun-2018 | C12Q1/6886 |
Clear Gene Signals
Clear Gene Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Portfolia | Venture Capital | Minority | ||
| Asymmetry Ventures | Venture Capital | Minority | ||
| DV Collective | Venture Capital | Minority | ||
| Founders, Inc | Venture Capital | Minority | ||
| Halo Labs (United States) | Angel Group | Minority |
Clear Gene FAQs
-
When was Clear Gene founded?
Clear Gene was founded in 2012.
-
Where is Clear Gene headquartered?
Clear Gene is headquartered in San Carlos, CA.
-
What is the size of Clear Gene?
Clear Gene has 4 total employees.
-
What industry is Clear Gene in?
Clear Gene’s primary industry is Biotechnology.
-
Is Clear Gene a private or public company?
Clear Gene is a Private company.
-
What is Clear Gene’s current revenue?
The current revenue for Clear Gene is .
-
How much funding has Clear Gene raised over time?
Clear Gene has raised $150K.
-
Who are Clear Gene’s investors?
Portfolia, Asymmetry Ventures, DV Collective, Founders, Inc, and Halo Labs (United States) are 5 of 9 investors who have invested in Clear Gene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process